CTT Pharmaceutical Holdings, Inc. (CTTH)
- Previous Close
0.0400 - Open
0.0400 - Bid --
- Ask --
- Day's Range
0.0400 - 0.0400 - 52 Week Range
0.0030 - 0.1000 - Volume
3,500 - Avg. Volume
20,742 - Market Cap (intraday)
1.936M - Beta (5Y Monthly) 0.25
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0100 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
CTT Pharmaceutical Holdings, Inc. engages in the development of oral drug delivery systems for pain management and treatment. It focuses on fast dissolving drug delivery systems. The company's technology platform includes the development of advanced oral delivery thin wafers infused with both natural and/or synthetic cannabis extracts to deliver treatment as an alternate to smoking and ingestion. Its principal asset is a patented orally administered wafer, an orally administrable wafer comprising at least one physiologically acceptable film forming agent. The company was formerly known as Mindesta Inc. and changed its name to CTT Pharmaceutical Holdings, Inc. in July 2015. The company is based in Ottawa, Canada.
www.cttpharmaceuticals.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Related News
Performance Overview: CTTH
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CTTH
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CTTH
Valuation Measures
Market Cap
1.94M
Enterprise Value
1.94M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
-1.83
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-153.57%
Return on Equity (ttm)
-448.83%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-1.67M
Diluted EPS (ttm)
-0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
32.12k
Total Debt/Equity (mrq)
11.87%
Levered Free Cash Flow (ttm)
-216.98k
Company Insights: CTTH
CTTH does not have Company Insights